New Launch26 Feb 2025, 04:28 pm
Zydus Lifesciences Launches First Quadrivalent Influenza Vaccine in India
AI Summary
Zydus Lifesciences Ltd, a leading global pharmaceutical company, is set to launch the first quadrivalent influenza vaccine, VaxiFlu-4, in India. The vaccine, developed at the Vaccine Technology Centre in Ahmedabad, offers protection against four new strains of the influenza virus. It has been cleared by the Central Drug Laboratory and will be marketed by Zydus Vaxxicare. The vaccine is a significant step towards preventing flu outbreaks and addressing healthcare challenges in India.
Key Highlights
- Zydus Lifesciences to launch the first quadrivalent influenza vaccine, VaxiFlu-4, in India.
- VaxiFlu-4 offers protection against four new strains of the influenza virus.
- The vaccine has been developed at the Vaccine Technology Centre in Ahmedabad.
- VaxiFlu-4 has been cleared by the Central Drug Laboratory.
- The vaccine is a significant step towards preventing flu outbreaks and addressing healthcare challenges in India.